Table 2. Respiratory support.
| Favipiravir initiation time | ≤72 h (n = 133) | >72 h (n = 47) | P-value |
|---|---|---|---|
| Supplemental oxygen | 104 | 2 | 0.0001 |
| High-flow nasal oxygen | 2 | 7 | 0.02 |
| Non-invasive mechanical ventilation | 4 | 3 | 0.3 |
| Invasive ventilation | 23 | 35 | 0.001 |
| Favipiravir initiation time | ≤72 h (n = 133) | >72 h (n = 47) | P-value |
|---|---|---|---|
| Supplemental oxygen | 104 | 2 | 0.0001 |
| High-flow nasal oxygen | 2 | 7 | 0.02 |
| Non-invasive mechanical ventilation | 4 | 3 | 0.3 |
| Invasive ventilation | 23 | 35 | 0.001 |